These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 23856032)
1. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer. Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032 [TBL] [Abstract][Full Text] [Related]
2. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
3. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer. Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673 [TBL] [Abstract][Full Text] [Related]
4. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291 [TBL] [Abstract][Full Text] [Related]
5. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG. Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539 [TBL] [Abstract][Full Text] [Related]
6. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription. Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312 [TBL] [Abstract][Full Text] [Related]
7. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer. Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471 [TBL] [Abstract][Full Text] [Related]
8. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055 [TBL] [Abstract][Full Text] [Related]
9. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer. Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155 [TBL] [Abstract][Full Text] [Related]
10. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression. Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351 [TBL] [Abstract][Full Text] [Related]
11. FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL. Wei P; Zhang N; Wang Y; Li D; Wang L; Sun X; Shen C; Yang Y; Zhou X; Du X Int J Biol Sci; 2015; 11(2):186-98. PubMed ID: 25561901 [TBL] [Abstract][Full Text] [Related]
12. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells. Li J; Wang Y; Luo J; Fu Z; Ying J; Yu Y; Yu W FEBS Lett; 2012 Oct; 586(20):3761-5. PubMed ID: 23010597 [TBL] [Abstract][Full Text] [Related]
13. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy. Wierstra I Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513 [TBL] [Abstract][Full Text] [Related]
14. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype. Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316 [TBL] [Abstract][Full Text] [Related]
15. Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer. Kyuno T; Kohno T; Konno T; Yamaguchi H; Kyuno D; Imamura M; Kimura Y; Kojima T; Takemasa I Pancreas; 2020 Feb; 49(2):273-280. PubMed ID: 32011531 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer. Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097 [TBL] [Abstract][Full Text] [Related]
17. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2. Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172 [TBL] [Abstract][Full Text] [Related]
18. Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer. Wang Y; Yao B; Wang Y; Zhang M; Fu S; Gao H; Peng R; Zhang L; Tang J Int J Mol Med; 2014 Jun; 33(6):1514-22. PubMed ID: 24676803 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer. Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943 [TBL] [Abstract][Full Text] [Related]
20. Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition. Jing Y; Cui D; Guo W; Jiang J; Jiang B; Lu Y; Zhao W; Wang X; Jiang Q; Han B; Xia S Cancer Lett; 2014 Jun; 348(1-2):135-45. PubMed ID: 24662746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]